Code of Maine Rules
02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION
373 - BOARD OF LICENSURE IN MEDICINE
Chapter 5 - COLLABORATIVE DRUG THERAPY MANAGEMENT(Board of Licensure in Medicine)
- Section 373-5-1 - Definitions
- Section 373-5-2 - Application
- Section 373-5-3 - Collaborative Practice Agreement Content
- Section 373-5-4 - Treatment Protocol Content
- Section 373-5-5 - Notifications
- Section 373-5-6 - Recordkeeping Requirements
- Section 373-5-7 - Complaints
- Section 373-5-8 - Duty to Report Disciplinary Action
Summary: This is a joint rule of the Board of Licensure in Medicine and the Board of Pharmacy for purposes of establishing safe and effective collaborative practice agreements, treatment protocols, and documentation and reporting requirements between a pharmacist and a practitioner.
Acknowledgment.The Boards recognize that the Maine Legislature enacted 2013 Public Law Chapter 308 to allow collaborative practice agreements between authorized practitioners and pharmacists and to expand access to healthcare while ensuring that all patients receive the most appropriate healthcare possible and to provide safe and efficient care to the citizens of Maine.
STATUTORY AUTHORITY:
32 MRS §3269(3), (7) (Board of Licensure in Medicine)